跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 558 条关于
“CD46”
全部
558
临床试验
341
药物
178
机构
0
资讯
39
8个月前
FibroGen Rebrands as Kyntra Bio, Advances CD46-Targeting ADC and Roxadustat Programs
去年
CD46-Targeting ADC FG-3246 Shows Promising Results in Advanced Prostate Cancer Trial
6个月前
Kyntra Bio's FG-3246 ADC Shows Promising Results in Metastatic Prostate Cancer Combination Trial
去年
AstraZeneca Acquires FibroGen China for $160 Million, Strengthening Roxadustat Position
2年前
FibroGen Terminates Pamrevlumab Development After Failed Pancreatic Cancer Trials, Announces Major Workforce Reduction
3个月前
Oncovita Unveils Promising Preclinical Data for MVdeltaC, a Modified Measles Virus Immunotherapy, at EACR 2026
2年前
FibroGen Highlights Pamrevlumab's Potential in Pancreatic Cancer and Roxadustat's Growth in Q1 2024 Earnings Call
3年前
SEA-CD40 Combo Shows Antitumor Activity in Pancreatic Cancer
去年
CD40 and CD70 Targeted Therapies Show Promise in Clinical Trials for Cancer and Autoimmune Diseases
2年前
CD47-Targeted Immunotherapies Show Promise in Cancer Treatment
第 1 页,共 4 页
上一页
下一页